Exclusive: NTx raises $47.5M Series B to commercialize protein, mRNA manufacturing platforms
Early-stage biomanufacturer Nature’s Toolbox (NTx) has collected $47.5 million in a Series B raise to bring its mRNA and protein production platforms to market, as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
